Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies.
Chen S, Zhu H, Jin M, Yuan H, Liu Z, Li J, Zhang X, Meng L, Li T, Diao Y, Gao H, Hong C, Zhu X, Zheng J, Li F, Niu Y, Ma T, Li X.
Chen S, et al. Among authors: ma t.
Cancer Med. 2022 Nov;11(22):4122-4133. doi: 10.1002/cam4.4764. Epub 2022 May 8.
Cancer Med. 2022.
PMID: 35526267
Free PMC article.